Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications.


Journal

European geriatric medicine
ISSN: 1878-7649
Titre abrégé: Eur Geriatr Med
Pays: Switzerland
ID NLM: 101533694

Informations de publication

Date de publication:
08 2021
Historique:
received: 20 02 2021
accepted: 15 04 2021
pubmed: 26 5 2021
medline: 7 8 2021
entrez: 25 5 2021
Statut: ppublish

Résumé

In the pathogenesis of severe COVID-19 complications, derangements of renin-angiotensin-aldosterone system (RAAS), vascular endothelial dysfunction leading to inflammation and coagulopathy, and arrhythmias play an important role. Therefore, it is worth considering the use of currently available drugs to protect COVID-19 patients with cardiovascular diseases. We review the current experience of conventional cardiovascular drugs [angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, anticoagulants, acetosalicylic acid, antiarrhythmic drugs, statins] as well as some other drug classes (antidiabetic drugs, vitamin D and NSAIDs) frequently used by older patients with cardiovascular diseases. Data were sought from clinical databases for COVID-19 and appropriate key words. Conclusions and recommendations are based on a consensus among all authors. Several cardiovascular drugs have a potential to protect patients with COVID-19, although evidence is largely based on retrospective, observational studies. Despite propensity score adjustments used in many analyses observational studies are not equivalent to randomised controlled trials (RCTs). Ongoing RCTs include treatment with antithrombotics, pulmonary vasodilators, RAAS-related drugs, and colchicine. RCTs in the acute phase of COVID-19 may not, however, recognise the benefits of long term anti-atherogenic therapies, such as statins. Most current cardiovascular drugs can be safely continued during COVID-19. Some drug classes may even be protective. Age-specific data are scarce, though, and conditions which are common in older patients (frailty, comorbidities, polypharmacy) must be individually considered for each drug group.

Identifiants

pubmed: 34031865
doi: 10.1007/s41999-021-00504-5
pii: 10.1007/s41999-021-00504-5
pmc: PMC8143992
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Angiotensin-Converting Enzyme Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

725-739

Investigateurs

None Grodzicki
None Strandberg

Informations de copyright

© 2021. The Author(s).

Références

BMJ Open. 2020 Dec 4;10(12):e044421
pubmed: 33277291
Therapie. 2020 Jul - Aug;75(4):327-333
pubmed: 32425249
J Am Coll Cardiol. 2021 Feb 2;77(4):437-449
pubmed: 33509400
J Am Med Dir Assoc. 2021 Jan;22(1):193-198
pubmed: 33232684
Br J Clin Pharmacol. 2021 Mar;87(3):776-784
pubmed: 32805057
Cell Metab. 2020 Aug 4;32(2):176-187.e4
pubmed: 32592657
Eur J Intern Med. 2020 Jul;77:158-160
pubmed: 32564905
Clin Interv Aging. 2020 Jul 21;15:1231-1240
pubmed: 32764907
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546
pubmed: 32517963
Lancet. 2020 May 30;395(10238):1705-1714
pubmed: 32416785
SN Compr Clin Med. 2020;2(12):2718-2721
pubmed: 33134845
Int J Neurosci. 2022 Sep;132(9):917-924
pubmed: 33175635
Circulation. 2020 Jul 28;142(4):315-317
pubmed: 32478567
J Infect Public Health. 2020 Oct;13(10):1373-1380
pubmed: 32605780
J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2
pubmed: 32674818
Diabetes Metab J. 2021 Mar;45(2):251-259
pubmed: 33752274
Am J Cardiovasc Drugs. 2020 Oct;20(5):413-418
pubmed: 32737841
Intern Emerg Med. 2020 Nov;15(8):1573-1576
pubmed: 33011928
Blood Transfus. 2020 May;18(3):226-229
pubmed: 32453688
Am Heart J. 2021 Feb;232:105-115
pubmed: 33121978
J Diabetes Investig. 2020 Sep;11(5):1104-1114
pubmed: 32558211
J Health Econ Outcomes Res. 2020 Sep 29;7(2):165-174
pubmed: 33043063
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
Cells. 2019 Dec 30;9(1):
pubmed: 31905994
Diabetes Metab. 2020 Nov;46(6):423-426
pubmed: 32750451
Bioessays. 2020 Nov;42(11):e2000094
pubmed: 32815593
Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):157-164
pubmed: 33135047
J Clin Lipidol. 2021 May-Jun;15(3):451-459
pubmed: 33726984
Am J Cardiol. 2021 Mar 1;142:158-159
pubmed: 33417877
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
BMJ. 2020 Mar 27;368:m1185
pubmed: 32220865
Front Immunol. 2020 Jun 23;11:1523
pubmed: 32655583
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
Crit Care. 2020 Jul 14;24(1):429
pubmed: 32664990
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):509-512
pubmed: 32388330
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Am J Med Sci. 2021 Jun;361(6):725-730
pubmed: 33667433
Int J Environ Res Public Health. 2020 May 22;17(10):
pubmed: 32456064
Circulation. 2009 Aug 18;120(7):636-44
pubmed: 19687370
Cell Discov. 2020 Oct 29;6(1):77
pubmed: 33298897
Lancet Respir Med. 2018 Sep;6(9):691-698
pubmed: 30078618
J Bras Nefrol. 2020 Aug 26;42(2 suppl 1):47-48
pubmed: 32877500
J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826
pubmed: 32860872
EClinicalMedicine. 2021 Mar;33:100765
pubmed: 33655204
Oxf Open Immunol. 2020;1(1):iqaa001
pubmed: 33047740
Front Med (Lausanne). 2020 Nov 17;7:584870
pubmed: 33330541
Rev Med Virol. 2021 May;31(3):e2180
pubmed: 33022834
Europace. 2021 Feb 5;23(2):313
pubmed: 32526011
Age Ageing. 2020 Feb 27;49(2):258-263
pubmed: 31755909
Tohoku J Exp Med. 2020;252(1):73-84
pubmed: 32908083
Intern Emerg Med. 2020 Aug;15(5):751-753
pubmed: 32297089
J Am Heart Assoc. 2020 Dec 15;9(24):e018475
pubmed: 33092446
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217
pubmed: 32519894
Eur Heart J. 2020 Sep 1;41(32):3038-3044
pubmed: 32882706
Vasc Biol. 2020 Dec 11;3(1):R1-R14
pubmed: 33537555
Medicine (Baltimore). 2020 Nov 20;99(47):e23365
pubmed: 33217881
Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):442-446
pubmed: 33748678
Sci Rep. 2020 Oct 1;10(1):16200
pubmed: 33004837
Diabetes Care. 2020 Jul;43(7):1399-1407
pubmed: 32409498
J Thromb Haemost. 2021 Dec;19(12):3080-3089
pubmed: 34538017
J Clin Pharm Ther. 2020 Dec;45(6):1244-1252
pubmed: 32767823
Diabetes Res Clin Pract. 2021 Jan;171:108444
pubmed: 32946854
Int J Cardiol Heart Vasc. 2020 Dec;31:100627
pubmed: 32875060
Immunopharmacol Immunotoxicol. 2021 Feb;43(1):37-50
pubmed: 33406943
Kardiologiia. 2020 Sep 07;60(8):4-15
pubmed: 33155953
Drugs. 2020 Sep;80(14):1383-1396
pubmed: 32705604
JAMA. 2021 Jan 19;325(3):254-264
pubmed: 33464336
Front Endocrinol (Lausanne). 2020 Oct 08;11:582936
pubmed: 33133024
F1000Res. 2020 Oct 6;9:1203
pubmed: 33145015
Metabolism. 2020 Aug;109:154276
pubmed: 32470350
Diabetes Metab. 2021 Nov;47(6):101220
pubmed: 33359486
Am J Clin Nutr. 2021 May 8;113(5):1275-1281
pubmed: 33515005
Anesth Analg. 2021 Apr 1;132(4):930-941
pubmed: 33093359
Diabetes Metab. 2021 Mar;47(2):101202
pubmed: 33091555
Front Immunol. 2020 Sep 30;11:588724
pubmed: 33117402
Cell Calcium. 2009 Jul;46(1):1-17
pubmed: 19535138
JAMA. 2021 Mar 16;325(11):1053-1060
pubmed: 33595634
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
EClinicalMedicine. 2020 Dec;29:100639
pubmed: 33251499
J Diabetes Sci Technol. 2020 Jul;14(4):745-747
pubmed: 32486846
J Clin Anesth. 2020 Dec;67:110005
pubmed: 32707517
Lancet Diabetes Endocrinol. 2020 Sep;8(9):735-736
pubmed: 32758429
Sci Rep. 2020 Oct 15;10(1):17458
pubmed: 33060704
Diabetes Metab. 2021 May;47(3):101250
pubmed: 33744398
Am J Hypertens. 2020 Dec 31;33(12):1102-1111
pubmed: 32920644
Neurol Sci. 2021 Jan;42(1):25-33
pubmed: 33140308
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Diabetologia. 2020 Aug;63(8):1500-1515
pubmed: 32472191
Eur J Endocrinol. 2019 Apr;180(4):P23-P54
pubmed: 30721133
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Am J Cardiovasc Drugs. 2021 Sep;21(5):499-512
pubmed: 33369719
J Thromb Haemost. 2020 Aug;18(8):1859-1865
pubmed: 32459046
Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):637-640
pubmed: 33593686
Diabetes Res Clin Pract. 2020 May;163:108146
pubmed: 32283128
Trials. 2020 Dec 28;21(1):1031
pubmed: 33371905
Europace. 2018 May 1;20(5):731-732an
pubmed: 29438514
Am J Hematol. 2021 Apr 1;96(4):471-479
pubmed: 33476420
J Med Virol. 2021 May;93(5):2705-2721
pubmed: 33463727
Endocr Rev. 2020 Jun 1;41(3):
pubmed: 32294179
Trends Cardiovasc Med. 2020 Nov;30(8):451-460
pubmed: 32814095
Mol Med. 2020 Aug 17;26(1):80
pubmed: 32807075
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
J Intern Med. 2021 Jan;289(1):131-133
pubmed: 32652766
J Cardiol. 2021 May;77(5):482-491
pubmed: 33168337
ERJ Open Res. 2020 Jul 13;6(2):
pubmed: 32685436
Postgrad Med J. 2022 Feb;98(1156):87-90
pubmed: 33184146
Am J Ther. 2020 Nov/Dec;27(6):e599-e610
pubmed: 33156016
Cardiol J. 2020;27(4):421-424
pubmed: 32643141
PLoS Med. 2020 Sep 8;17(9):e1003308
pubmed: 32898149
Clin Exp Pharmacol Physiol. 2021 Jun;48(6):823-830
pubmed: 33719081
Chest. 2021 Mar;159(3):1182-1196
pubmed: 33217420
Pathogens. 2020 Sep 17;9(9):
pubmed: 32957539
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620960797
pubmed: 33079569
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet Diabetes Endocrinol. 2021 May;9(5):276-292
pubmed: 33798465
Diabetes Obes Metab. 2020 Oct;22(10):1946-1950
pubmed: 32463179
BMJ. 2021 Mar 4;372:n544
pubmed: 33664083
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):135-136
pubmed: 32282032
Eur J Prev Cardiol. 2022 Feb 3;28(17):1885-1894
pubmed: 33624076
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
Diabetes Res Clin Pract. 2020 Jul;165:108268
pubmed: 32533990
Endocrine. 2021 Feb;71(2):270-272
pubmed: 33219496
Nat Rev Cardiol. 2020 Sep;17(9):543-558
pubmed: 32690910
Drugs. 2021 Apr;81(6):685-695
pubmed: 33782908
Open Heart. 2020 Nov;7(2):
pubmed: 33154144
medRxiv. 2020 Sep 02;:
pubmed: 32909011
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471
Am J Cardiol. 2020 Dec 1;136:149-155
pubmed: 32946859
N Engl J Med. 2014 Oct 30;371(18):1695-703
pubmed: 25268516
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):e175-e182
pubmed: 33535790
J Steroid Biochem Mol Biol. 2020 Oct;203:105751
pubmed: 32871238
Nat Commun. 2021 Feb 26;12(1):1325
pubmed: 33637713
Int J Mol Sci. 2020 Nov 15;21(22):
pubmed: 33203141
J Am Heart Assoc. 2021 Feb 2;10(3):e019669
pubmed: 33307964

Auteurs

Mariana Alves (M)

Faculty of Medicine, Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Serviço de Medicina III, Hospital Pulido Valente, CHULNUniversity of LisbonUniversidade de Lisboa, Lisbon, Portugal.

Marília Andreia Fernandes (MA)

Department of Internal Medicine, Hospital Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

Gülistan Bahat (G)

Istanbul Medical School, Department of Internal Medicine, Division of Geriatrics, Istanbul University, Capa, 34093, Istanbul, Turkey.

Athanase Benetos (A)

Department of Geriatrics and FHU CARTAGE-PROFILES, CHRU de Nancy and INSERM 1116, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Hugo Clemente (H)

Department of Geriatrics, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium.

Tomasz Grodzicki (T)

Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Cracow, Poland.

Manuel Martínez-Sellés (M)

Department of Cardiology, Hospital General Universitario Gregorio Marañón, CIBER-CV. Universidad Europea, Universidad Complutense, Madrid, Spain.

Francesco Mattace-Raso (F)

Division of Geriatrics, Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Chakravarthi Rajkumar (C)

Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Andrea Ungar (A)

Department of Geriatrics and Intensive Care Unit, University of Florence and Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.

Nikos Werner (N)

Heart Center Trier, Krankenhaus der Barmherzigen Brüder, Trier, Germany.

Timo E Strandberg (TE)

Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, PO Box 340, N00029, Helsinki, Finland. timo.strandberg@oulu.fi.
University of Oulu, Center for Life Course Health Research, Oulu, Finland. timo.strandberg@oulu.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH